Search

everythinglearnresearchcommunity

for

Search:↓

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Hair loss increases with age; alcohol raises risk, more female partners lowers it.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

Plant-based compounds may offer safer prostate cancer treatment with fewer side effects.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

The structure of SRD5A reveals how it reduces steroids, aiding drug design for related health conditions.

Male cancer patients have a higher risk of severe illness and death from COVID-19 than female patients.

Low doses of BPA can increase prostate growth and change hormone levels in adult rats.

Analog 23 is a promising compound for prostate cancer treatment.

Pumpkin seeds may improve health due to their rich nutrients and potential to treat various conditions.

Bald men may have a lower risk of testicular cancer.

Onions may help reduce cancer risk and obesity-related issues.

People with androgenetic alopecia may have a higher risk of peripheral venous disorders.

Using steroids can increase the risk of heart problems.

High TNF-α levels may increase hair loss risk after PRP therapy.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

HPV genes and estradiol increase a cancer-related signaling pathway, which may be targeted for cervical cancer treatment.

Lower SHBG levels may increase the risk of PCOS.

The number of advanced breast cancer cases in women under 40 has increased, but the overall numbers are still low.

Finasteride reduces urinary issues and surgery need in men with enlarged prostates by over 50%.

Finasteride and methadone don't increase advanced liver disease risk in HCV+ male veterans.

Both genes and environmental factors like chemicals may contribute to the increase in hypospadias, but the exact causes are still unclear.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

High doses of cyproterone acetate are linked to an increased risk of developing meningioma.

Some men with early hair loss may have a male version of PCOS, affecting hormones and increasing health risks.

Using 5-alpha reductase inhibitors may increase the risk of mild depression.

Longer TA repeats in the SRD5A2 gene may increase acne risk in Chinese people.

Alopecia treatments like 5α-reductase inhibitors and spironolactone are safe for breast cancer patients and high-risk women.

Plant-based compounds might be a promising alternative for prostate cancer treatment with fewer side effects.